Media Coverage

Sabinsa Corporation has announced the results of a recent study conducted by researchers at Vanderbilt University, which involved 120 subjects with an average selenium intake of 10 micrograms per day (well below the recommended 55mg per day) who were provided with selenium supplements in either the form of sodium selenite or selenomethionine (Selenium SeLECT®). The researchers found that less than half the amount of selenium as selenomethionine was needed to reach optimal levels compared to selenium as selenite, indicating that it is more bioavailable. This study has been accepted for publication in the American Journal of Clinical Nutrition.

    HEADQUARTERS

  • Sami-Sabinsa Group
    19/1 & 19/2, Ⅰ Main, Ⅱ Phase
    Peenya Industrial Area
    Bangalore - 560 058
    Karnataka, India

  • +91 80 6852 7706
  • info@sami-sabinsagroup.com

CERTIFICATES

Certificate Logos Certificate Logos
Certificate Logos Certificate Logos

CONTACT US

Disclaimer

Please note that this website and information provided herein is not for final consumers of a finished food, beverage, dietary supplement product or cosmetic product, as the information contained herein does not refer to finished products for consumers.

The information provided on the website is intended only for producers of finished food, beverage, dietary supplement and cosmetic product.

The statements related to ingredients on the website, have not been evaluated by the Food and Drug Administration and are not intended to diagnose, treat, cure, or prevent any disease.

The website and information herein are available in various countries across the world, and hence statements or product information including its classification may not be applicable in your country.

Information and statements provided on the website, shall not be construed as license to practice, or recommendations to infringe, any patents or other intellectual property rights of Sabinsa and others.

By browsing further, You understand the above terms.